Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-042290

Chief Operating Officer sold 14,583 shares at $40.00 ($583,320)

  • Chief Operating Officer acquired 14,583 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ADAMS R MARK Chief Operating Officer 2021-06-17 Option exercise +14,583 $28.10 $409,782 72,687 D: show line 1 in the form
ADAMS R MARK Chief Operating Officer 2021-06-17 Sale −14,583 $40.00 $583,320 58,104 D: show line 2 in the form
Open-market sales · 14,583 sh · avg $40.00 · $583,320

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
ADAMS R MARK Chief Operating Officer 2021-06-17 Option exercise · Stock Option (Right to Buy) −14,583 35,417 D: show line 3 in the form
Loading xslF345X03/doc4.xml…